Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
Part of paid clinical trials in Lady Lake, Florida.
- Sponsor
- Fibronostics USA, Inc
- Study ID
- NCT06797596
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alcohol Liver Disease
- Liver Fibrosis Due to NASH
- MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Study Details
This is a retrospective cross-sectional research intended to explore the utility of LIVERFASt in the clinical pathways for the detection of liver fibrosis and steatosis in comparison with the Magnetic Resonance Elastography (MRE) and MRct1 fibrosis classification (historical records) and to assess LIVERFASt performance for MR steatosis assessment in an United States adult miscellaneous population with available (historical) MR intracellular fat fraction assessment (ICFF) from a single tertiary US clinic.
Key Dates
- Start date
- May 31, 2025
- Status verified
- Jan 2025
- Primary completion
- Jul 15, 2025
- Completion
- Aug 30, 2025
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Clinical correlation evaluation of the LIVERFAStTM Test for diagnosing important liver lesions of fibrosis and steatosis against Magnetic Resonance Elastography for Liver Fibrosis and MR-based assessment of steatosis, in adult US population. [ Time Frame: 6 months ]
Central Contacts
- Garth George, MD352-638-3982
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Advanced Gastroenterology & Surgery Associates | Lady Lake | Florida | 32159 | - |
Find similar trials in Lady Lake, FL
Related Studies
- RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)PHASE2 · Recruiting · Altimmune, Inc. · Peoria, Arizona
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIVPHASE2 · Recruiting · Naga P. Chalasani · Birmingham, Alabama
- Quantitative Ultrasound to Assess Steatotic Liver Disease in ChildrenRecruiting · University of California, San Diego · La Jolla, California
- Assessment of Non-Invasive Testing in Major Liver-Related OutcomesEnrolling By Invitation · HRI-MAIL-NIT · Chandler, Arizona